NCT04962581 - Clinical Trial References

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Citation(s)

Kiwakyou L
BJ. Free and Simple Confirmation of Lung Isolation adequacy. [Thoracic Anesthesia Symposium 2021, Poster Presentation #30]. In press 2021
Yamamoto Y, Watanabe S, Kano T
Gradient of bronchial end-tidal CO2 during two-lung ventilation in lateral decubitus position is predictive of oxygenation disorder during subsequent one-lung ventilation. J Anesth. 2009;23(2):192-7. doi: 10.1007/s00540-008-0737-9. Epub 2009 May 15.

A Prospective Descriptive Study of the Individualized Capnography of Both Lungs During Single Lung Ventilation With Double-lumen Tube

Clinical trial NCT04962581 - References